Multiple studies enrolling patients with T2D have found that serum ADA levels are significantly higher in those with T2D than in those without T2D and are associated with poor glycemic control and insulin resistance (13, 14, 15). This evidence concerns the gene ADA and type 2 diabetes mellitus.